{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:17:51Z","timestamp":1792034271207,"version":"4.4.0"},"reference-count":123,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Italian Mininster of Health","award":["GR-2008-1145270"],"award-info":[{"award-number":["GR-2008-1145270"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.bbalip.2014.12.018","type":"journal-article","created":{"date-parts":[[2015,1,14]],"date-time":"2015-01-14T12:07:39Z","timestamp":1421237259000},"page":"1095-1105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":102,"title":["The impairment of cholesterol metabolism in Huntington disease"],"prefix":"10.1016","volume":"1851","author":[{"given":"Valerio","family":"Leoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Caccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbalip.2014.12.018_bb0005","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0022-2275(20)38456-X","article-title":"Serum lathosterol concentration is an indicator of whole-body cholesterol synthesis in humans","volume":"29","author":"Kempen","year":"1988","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0010","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0021-9258(18)65019-7","article-title":"Synthesis of lanosterol in vivo","volume":"224","author":"Bloch","year":"1957","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0015","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s11745-000-0616-9","article-title":"Deuterium uptake and plasma cholesterol precursor levels correspond as methods for measurement of endogenous cholesterol synthesis in hypercholesterolemic women","volume":"35","author":"Matthan","year":"2000","journal-title":"Lipids"},{"key":"10.1016\/j.bbalip.2014.12.018_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-024914-5.50008-5","article-title":"Regulation of HMG-CoA reductase","volume":"14","author":"Rodwell","year":"1976","journal-title":"Adv. Lipid Res."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0025","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1172\/JCI0215593","article-title":"SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver","volume":"109","author":"Horton","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2009.12.080","article-title":"24S-hydroxycholesterol effects on lipid metabolism genes are modeled in traumatic brain injury","volume":"1319","author":"Cartagena","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0035","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1021\/pr7006076","article-title":"The effect of 24S-hydroxycholesterol on cholesterol homeostasis in neurons: quantitative changes to the cortical neuron proteome","volume":"7","author":"Wang","year":"2008","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0040","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev.biochem.72.121801.161712","article-title":"The enzymes, regulation, and genetics of bile acid synthesis","volume":"72","author":"Russell","year":"2003","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0045","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/S0022-2275(20)33481-7","article-title":"27-hydroxycholesterol: production rates in normal human subjects","volume":"40","author":"Duane","year":"1999","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0050","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.mam.2009.02.005","article-title":"Oxysterols, Sources, cellular storage and metabolism, and new insights into their roles in cholesterol homeostasis","volume":"30","author":"Brown","year":"2009","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0055","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1194\/jlr.R400004-JLR200","article-title":"Thematic review series, brain lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal","volume":"45","author":"Dietschy","year":"2004","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0060","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/j.1471-4159.2009.06408.x","article-title":"Cholesterol metabolism and transport in the pathogenesis of Alzheimer's disease","volume":"111","author":"Martins","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0065","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/nature04399","article-title":"Role of cholesterol and lipid organization in disease","volume":"438","author":"Maxfield","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.bbalip.2014.12.018_bb0075","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nrn2059","article-title":"Lipid raft microdomains and neurotransmitter signalling","volume":"8","author":"Allen","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0080","series-title":"Subcellular Biochemistry","first-page":"173","article-title":"Cholesterol and Myelin","author":"Snipe","year":"1997"},{"key":"10.1016\/j.bbalip.2014.12.018_bb0085","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1161\/01.ATV.0000120374.59826.1b","article-title":"Brain cholesterol: long secret life behind a barrier","volume":"24","author":"Bj\u00f6rkhem","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0090","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1096\/fj.00-0815fje","article-title":"Essential role for cholesterol in synaptic plasticity and neuronal degeneration","volume":"15","author":"Koudinov","year":"2001","journal-title":"FASEB J."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0095","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1007\/s00018-003-3018-7","article-title":"Cholesterol homeostasis and function in neurons of the central nervous system","volume":"60","author":"Pfrieger","year":"2003","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0100","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/bies.10195","article-title":"Outsourcing in the brain, do neurons depend on cholesterol delivery by astrocytes?","volume":"25","author":"Pfrieger","year":"2003","journal-title":"Bioessays"},{"key":"10.1016\/j.bbalip.2014.12.018_bb0105","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.plipres.2011.06.002","article-title":"Cholesterol metabolism in neurons and astrocytes","volume":"50","author":"Pfrieger","year":"2011","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0110","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1126\/science.1090776","article-title":"Generation of viable cholesterol-free mice","volume":"302","author":"Wechsler","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.bbalip.2014.12.018_bb0115","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0005-2760(87)90295-5","article-title":"Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins","volume":"917","author":"Pitas","year":"1987","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2014.12.018_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2202-8-1","article-title":"Survival of adult neurons lacking cholesterol synthesis in vivo","volume":"8","author":"F\u00fcnfschilling","year":"2007","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0125","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0306-4522(93)90456-P","article-title":"Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats","volume":"55","author":"Poirier","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbalip.2014.12.018_bb0130","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nrn2620","article-title":"Apolipoprotein E and its receptors in Alzheimer\u2019s disease, pathways, pathogenesis and therapy","volume":"10","author":"Bu","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0135","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2217\/17460875.3.5.505","article-title":"Apolipoprotein E and cholesterol in aging and disease in the brain","volume":"3","author":"Posse de Chaves","year":"2008","journal-title":"Futur. Lipidol."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0140","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1194\/jlr.R006338","article-title":"Genetic connections between neurological disorders and cholesterol metabolism","volume":"51","author":"Bj\u00f6rkhem","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0145","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.neurobiolaging.2007.08.005","article-title":"Total cholesterol and oxysterols: early markers for cognitive decline in elderly?","volume":"30","author":"van den Kommer","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbalip.2014.12.018_bb0150","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0005-2760(98)00047-2","article-title":"Transport of side-chain oxidized oxysterols in the human circulation","volume":"1392","author":"Babiker","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2014.12.018_bb0155","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0022-2275(20)37217-5","article-title":"High levels of (24S)-24-hydroxycholesterol 3-sulfate, 24-glucuronide in the serum and urine o children with severe cholestatic liver disease","volume":"38","author":"Meng","year":"1997","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0160","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/mt.2009.175","article-title":"Adeno-associated virus gene therapy with cholesterol 24-hydroxylase reduces the amyloid pathology before orafter the onset of amyloid plaques in mouse models of Alzheimer\u2019s disease","volume":"18","author":"Hudry","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0165","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.atherosclerosis.2006.09.026","article-title":"Lipoprotein distribution and biological variation of 24S- and 27-hydroxycholesterol in healthy volunteers","volume":"194","author":"Burkard","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbalip.2014.12.018_bb0170","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.numecd.2011.04.010","article-title":"Patterns of cholesterol metabolism: pathophysiological and therapeutic implications for dyslipidemias and the metabolic syndrome","volume":"21","author":"Lupattelli","year":"2011","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0175","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/j.freeradbiomed.2011.03.019","article-title":"Biomarkers of oxidative damage in cigarette smokers: which biomarkers might reflect acute versus chronic oxidative stress?","volume":"50","author":"Seet","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0180","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/WAD.0b013e3181d61fea","article-title":"Effects of simvastatin on cholesterol metabolism and Alzheimer disease biomarkers","volume":"24","author":"Serrano-Pozo","year":"2010","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0185","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0304-3940(00)01466-X","article-title":"Plasma levels of 24S-hydroxycholesterol in patients with neurological diseases","volume":"293","author":"Bretillon","year":"2000","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0190","doi-asserted-by":"crossref","first-page":"292598","DOI":"10.1155\/2012\/292598","article-title":"Cholesterol: its regulation and role in central nervous system disorders","volume":"2012","author":"Orth","year":"2012","journal-title":"Cholesterol"},{"key":"10.1016\/j.bbalip.2014.12.018_bb0200","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1194\/jlr.M200293-JLR200","article-title":"On the rate of translocation in vitro and kinetics in vivo of the major oxysterols in human circulation: critical importance of the position of the oxygen function","volume":"43","author":"Meaney","year":"2002","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0205","doi-asserted-by":"crossref","first-page":"9799","DOI":"10.1073\/pnas.93.18.9799","article-title":"Cholesterol homeostasis in human brain, evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation","volume":"93","author":"L\u00fctjohann","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0210","doi-asserted-by":"crossref","first-page":"7238","DOI":"10.1073\/pnas.96.13.7238","article-title":"cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain","volume":"6","author":"Lund","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0215","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1002\/cne.21605","article-title":"Neuronal expression and subcellular localization of cholesterol 24-hydroxylase in the mouse brain","volume":"507","author":"Ramirez","year":"2008","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0220","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1194\/jlr.M300164-JLR200","article-title":"Quantification of two pathways for cholesterol excretion from the brain in normal mice and mice with neurodegeneration","volume":"44","author":"Xie","year":"2003","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0225","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1365-2796.2006.01725.x","article-title":"Crossing the barrier, oxysterols as cholesterol transporters and metabolic modulators in the brain","volume":"260","author":"Bj\u00f6rkhem","year":"2006","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0230","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0304-3940(01)02277-7","article-title":"On the turnover of brain cholesterol in patients with Alzheimer\u2019s disease. Abnormal induction of the cholesterol-catabolic enzyme CYP46 in glial cells","volume":"314","author":"Bogdanovic","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0235","doi-asserted-by":"crossref","first-page":"34674","DOI":"10.1074\/jbc.M402324200","article-title":"Differential expression of cholesterol hydroxylases in Alzheimer\u2019s disease","volume":"279","author":"Brown","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0240","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1097\/01.jnen.0000225906.82428.69","article-title":"Lovastatin modulates increased cholesterol and oxysterol levels and has a neuroprotective effect on rat hippocampal neurons after kainate injury","volume":"65","author":"He","year":"2006","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0250","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00418-010-0718-6","article-title":"Brain injury induces cholesterol 24-hydroxylase (Cyp46) expression in glial cells in a time-dependent manner","volume":"134","author":"Smiljanic","year":"2010","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0255","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1002\/jnr.21266","article-title":"24S-hydroxycholesterol in relation to disease manifestations of acute experimental autoimmune encephalomyelitis","volume":"85","author":"Teunissen","year":"2007","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0260","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1089\/neu.2007.0444","article-title":"Cortical injury increases cholesterol 24S hydroxylase (Cyp46) levels in the rat brain","volume":"25","author":"Cartagena","year":"2008","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.bbalip.2014.12.018_bb0265","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1073\/pnas.0600316103","article-title":"Brain cholesterol turnover required for geranylgeraniol production and learning in mice","volume":"103","author":"Kotti","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0270","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1146\/annurev.biochem.78.072407.103859","article-title":"Cholesterol 24-hydroxylase: an enzyme of cholesterol turnover in the brain","volume":"78","author":"Russell","year":"2009","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0275","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2796.2011.02389.x","article-title":"Enhanced production of 24S-hydroxycholesterol is not sufficient to drive liver X receptor target genes in vivo","volume":"270","author":"Shafaati","year":"2011","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0280","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1073\/pnas.0913828107","article-title":"ACAT1 gene ablation increases 24(S)-hydroxycholesterol content in the brain and ameliorates amyloid pathology in mice with AD","volume":"107","author":"Bryleva","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0285","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/j.1471-4159.2005.03441.x","article-title":"Regulation of hippocampal cholesterol metabolism by ApoE and environmental stimoulation","volume":"95","author":"Levi","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0290","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3233\/JAD-2009-1150","article-title":"Absence of ApoE upregulates murine brain ApoD and ABCA1 levels, but does not affect brain sterol levels, while human ApoE3 and human ApoE4 upregulate brain cholesterol precursor levels","volume":"18","author":"Jansen","year":"2009","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0295","doi-asserted-by":"crossref","first-page":"12799","DOI":"10.1074\/jbc.M601019200","article-title":"24(S)-hydroxycholesterol participates in a liver X receptor-controlled pathway in astrocytes that regulates apolipoprotein E-mediated cholesterol efflux","volume":"281","author":"Abildayeva","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0300","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1096\/fj.07-9944com","article-title":"ATP-binding cassette transporters G1 and G4 mediate cholesterol and desmosterol efflux to HDL and regulate sterol accumulation in the brain","volume":"22","author":"Wang","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0305","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.bcp.2013.03.015","article-title":"Potential diagnostic applications of side chain oxysterols analysis in plasma and cerebrospinal fluid","volume":"86","author":"Leoni","year":"2013","journal-title":"Biochem. Pharmacol."},{"issue":"6","key":"10.1016\/j.bbalip.2014.12.018_bb0310","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. The Huntington\u2019s Disease Collaborative Research Group","volume":"72","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.bbalip.2014.12.018_bb0315","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Richardson, Neuropathological classification of Huntington\u2019s disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0320","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.brainresbull.2006.10.028","article-title":"Change in MRI striatal volumes as a biomarker in preclinical Huntington\u2019s disease","volume":"72","author":"Aylward","year":"2007","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0325","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1111\/j.1460-9568.2008.06310.x","article-title":"Mechanisms of neurodegeneration in Huntington\u2019s disease","volume":"27","author":"Gil","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0330","doi-asserted-by":"crossref","first-page":"9932","DOI":"10.1523\/JNEUROSCI.3355-05.2005","article-title":"Dysfunction of the cholesterol biosynthetic pathway in Huntington\u2019s disease","volume":"25","author":"Valenza","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0335","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.nbd.2007.07.004","article-title":"Progressive dysfunction of the cholesterol biosynthesis pathway in the R6\/2 mouse model of Huntington\u2019s disease","volume":"28","author":"Valenza","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0340","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s40618-014-0098-1","article-title":"Altered expression of 3-betahydroxysterol delta-24-reductase\/selective Alzheimer's disease indicator-1 gene in Huntington's disease models","volume":"37","author":"Samara","year":"2014","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0345","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.mcn.2012.03.011","article-title":"Multiple phenotypes in Huntington disease mouse neural stem cells","volume":"50","author":"Ritch","year":"2012","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0350","article-title":"Pitfalls in the detection of cholesterol in Huntington's disease models","volume":"4","author":"Marullo","year":"2012","journal-title":"PLoS Curr."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0355","doi-asserted-by":"crossref","first-page":"10844","DOI":"10.1523\/JNEUROSCI.0917-10.2010","article-title":"Cholesterol defect is marked across multiple rodent models of Huntington\u2019s disease and is manifest in astrocytes","volume":"30","author":"Valenza","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0360","doi-asserted-by":"crossref","first-page":"9544","DOI":"10.1523\/JNEUROSCI.1291-11.2011","article-title":"Peroxisome-proliferator-activated receptor gamma coactivator 1 \u03b1 contributes to dysmyelination in experimental models of Huntington\u2019s disease","volume":"31","author":"Xiang","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0365","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/hmg\/ddt406","article-title":"Loss of caveolin-1 expression in knock-in mouse model of Huntington's disease suppresses pathophysiology in vivo","volume":"23","author":"Trushina","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0370","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1093\/hmg\/ddl434","article-title":"Mutant huntingtin inhibits clathrin-independent endocytosis and causes accumulation of cholesterol in vitro and in vivo","volume":"15","author":"Trushina","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0375","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1471-4159.2010.06912.x","article-title":"Altered cholesterol homeostasis contributes to enhanced excitotoxicity in Huntington\u2019s disease","volume":"115","author":"del Toro","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0380","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1083\/jcb.100.3.965","article-title":"Nile red: a selective fluorescent stain for intracellular lipid droplets","volume":"100","author":"Greenspan","year":"1985","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0385","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1194\/jlr.D300032-JLR200","article-title":"A novel cholesterol stain reveals early neuronal cholesterol accumulation in the Niemann\u2013Pick type C1 mouse brain","volume":"45","author":"Reid","year":"2004","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0390","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/hipo.20548","article-title":"Cholesterol-promoted synaptogenesis requires the conversion of cholesterol to estradiol in the hippocampus","volume":"19","author":"Fester","year":"2009","journal-title":"Hippocampus"},{"key":"10.1016\/j.bbalip.2014.12.018_bb0395","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.mcn.2005.02.006","article-title":"Multiple mechanisms mediate cholesterol-induced synaptogenesis in a CNS neuron","volume":"29","author":"Goritz","year":"2005","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0400","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.molmed.2003.08.006","article-title":"Huntington\u2019s disease: a synaptopathy?","volume":"9","author":"Li","year":"2003","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0405","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.tins.2004.08.008","article-title":"Genetic mouse models of Huntington\u2019s and Parkinson\u2019s diseases: illuminating but imperfect","volume":"27","author":"Levine","year":"2004","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0410","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1046\/j.1471-4159.2003.02305.x","article-title":"HMG-CoA reductase inhibition causes neurite loss by interfering with geranylgeranylpyrophosphate synthesis","volume":"89","author":"Schulz","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0415","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jns.2004.11.036","article-title":"Cholesterol homeostasis failure as a unifying cause of synaptic degeneration","volume":"229\u2013230","author":"Koudinov","year":"2005","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.aca.2013.06.012","article-title":"Raman spectroscopy and partial least squares analysis in discrimination of peripheral cells affected by Huntington's disease","volume":"793","author":"Muratore","year":"2013","journal-title":"Anal. Chim. Acta."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0425","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1136\/jmg.2009.066399","article-title":"Wild-type but not mutant huntingtin modulates the transcriptional activity of liver X receptors","volume":"46","author":"Futter","year":"2009","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0430","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nrneurol.2011.132","article-title":"Cholesterol metabolism in Huntington disease","volume":"7","author":"Karasinska","year":"2011","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0435","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.tins.2011.06.005","article-title":"Emerging roles for cholesterol in Huntington\u2019s disease","volume":"34","author":"Valenza","year":"2011","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0440","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S1474-4422(09)70170-X","article-title":"TRACK-HD investigators, biological and clinical manifestations of Huntington\u2019s disease in the longitudinal TRACK-HD study, cross-sectional analysis of baseline data","volume":"8","author":"Tabrizi","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0445","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/brain\/awq280","article-title":"Smaller intracranial volume in prodromal Huntington\u2019s disease: evidence for abnormal neurodevelopment","volume":"134","author":"Nopoulos","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.bbalip.2014.12.018_bb0450","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.pneurobio.2011.10.004","article-title":"PGC-1\u03b1 at the intersection of bioenergetics regulation and neuron function: from Huntington's disease to Parkinson's disease and beyond","volume":"97","author":"Tsunemi","year":"2012","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0455","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cmet.2006.10.004","article-title":"Thermoregulatory and metabolic defects in Huntington\u2019s disease transgenic mice implicate PGC-1alpha in Huntington\u2019s disease neurodegeneration","volume":"4","author":"Weydt","year":"2006","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0460","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","article-title":"Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration","volume":"127","author":"Cui","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.bbalip.2014.12.018_bb0465","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1172\/JCI45691","article-title":"Energy deficit in Huntington disease: why it matters","volume":"121","author":"Mochel","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0470","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1038\/emboj.2012.65","article-title":"Shaping the role of mitochondria in the pathogenesis of Huntington's disease","volume":"31","author":"Costa","year":"2012","journal-title":"EMBO J."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0475","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1093\/hmg\/ddt242","article-title":"A role of mitochondrial complex II defects in genetic models of Huntington's disease expressing N-terminal fragments of mutant huntingtin","volume":"22","author":"Damiano","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0480","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.mito.2013.05.006","article-title":"Mitochondrial respiratory chain complex activity and bioenergetics alterations in human platelets derived from pre-symptomatic and symptomatic Huntington's disease carriers","volume":"13","author":"Silva","year":"2013","journal-title":"Mitochondrion"},{"key":"10.1016\/j.bbalip.2014.12.018_bb0485","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1515\/rns.2011.060","article-title":"Mitochondrial and metabolic-based protective strategies in Huntington\u2019s disease: the case of creatine and coenzyme Q","volume":"23","author":"Naia","year":"2011","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0490","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jacl.2009.11.003","article-title":"Altered cholesterol and fatty acid metabolism in Huntington disease","volume":"4","author":"Block","year":"2010","journal-title":"J. Clin. Lipidol."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0495","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s12035-014-8663-3","article-title":"Mitochondrial membrane fluidity is consistently increased in different models of Huntington disease: restorative effects of olesoxime","volume":"50","author":"Eckmann","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0500","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1093\/hmg\/ddm170","article-title":"Cholesterol biosynthesis pathway is disturbed in YAC128 mice and is modulated by huntingtin mutation","volume":"16","author":"Valenza","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0505","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ymgme.2007.10.002","article-title":"Low plasma total cholesterol in patients with Huntington\u2019s disease and first-degree relatives","volume":"93","author":"Markianos","year":"2008","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0510","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3389\/fphys.2014.00231","article-title":"Metabolic and hormonal signatures in pre-manifest and manifest Huntington's disease patients","volume":"5","author":"Wang","year":"2014","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0515","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1093\/brain\/awn212","article-title":"Plasma 24S-hydroxycholesterol and caudate MRI in pre-manifest and early Huntington\u2019s disease","volume":"131","author":"Leoni","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.bbalip.2014.12.018_bb0520","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.neulet.2011.03.025","article-title":"Whole body cholesterol metabolism is impaired in Huntington\u2019s disease","volume":"494","author":"Leoni","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0525","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.chemphyslip.2011.04.002","article-title":"Oxysterols as biomarkers in neurodegenerative diseases","volume":"164","author":"Leoni","year":"2011","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.bbalip.2014.12.018_bb0530","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.biochi.2012.09.025","article-title":"24S-hydroxycholesterol in plasma: a marker of cholesterol turnover in neurodegenerative diseases","volume":"95","author":"Leoni","year":"2013","journal-title":"Biochimie"},{"key":"10.1016\/j.bbalip.2014.12.018_bb0535","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1055\/s-2003-43053","article-title":"24S-hydroxycholesterol: a marker of brain cholesterol metabolism","volume":"36","author":"L\u00fctjohann","year":"2003","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.bbalip.2014.12.018_bb0540","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/S0022-2275(20)32188-X","article-title":"Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation","volume":"39","author":"Bj\u00f6rkhem","year":"1998","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0545","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/S0022-2275(20)32393-2","article-title":"Plasma levels of 24S-hydroxycholesterol reflect the balance between cerebral production and hepatic metabolism and are inversely related to body surface","volume":"41","author":"Bretillon","year":"2000","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0550","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0304-3940(02)00887-X","article-title":"Changes in human plasma levels of 24S-hydroxycholesterol during progression of multiple sclerosis","volume":"331","author":"Leoni","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0555","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.neulet.2009.06.073","article-title":"Plasma levels of 24S-hydroxycholesterol reflect brain volumes in patients without objective cognitive impairment but not in those with Alzheimer\u2019s disease","volume":"462","author":"Solomon","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0560","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1097\/00001756-200006260-00030","article-title":"Plasma 24S-hydroxycholesterol, a peripheral indicator of neuronal degeneration and potential state marker for Alzheimer\u2019s disease","volume":"11","author":"Papassotiropoulos","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.bbalip.2014.12.018_bb0565","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.neulet.2004.07.031","article-title":"Altered levels of plasma 24S- and 27-hydroxycholesterol in demented patients","volume":"368","author":"K\u00f6lsch","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0570","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.neurobiolaging.2007.10.010","article-title":"Serum 24S-hydroxycholesterol and hippocampal size in middle-aged normal individuals","volume":"30","author":"Koschack","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbalip.2014.12.018_bb0575","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0304-3940(03)00667-0","article-title":"Decreased levels of the brain specific 24S-hydroxycholesterol and cholesterol precursors in serum of multiple sclerosis patients","volume":"347","author":"Teunissen","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0580","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.clineuro.2005.07.010","article-title":"Plasma cerebrosterol and magnetic resonance imaging measures in multiple sclerosis","volume":"108","author":"Danylait\u00e9 Karrenbauer","year":"2006","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0585","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ymgme.2011.12.005","article-title":"Metabolic consequences of mitochondrial coenzyme A deficiency in patients with PANK2 mutations","volume":"105","author":"Leoni","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0590","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/1471-2377-11-121","article-title":"Plasma 24S-hydroxycholesterol levels in elderly subjects with late onset Alzheimer\u2019s disease or vascular dementia: a case\u2013control study","volume":"11","author":"Zuliani","year":"2011","journal-title":"BMC Neurol."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0595","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.3233\/JAD-2010-100780","article-title":"Vitamin E and enzymatic\/oxidative stress-driven oxysterols in amnestic mild cognitive impairment subtypes and Alzheimer\u2019s disease","volume":"21","author":"Iuliano","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0600","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0022-2275(20)32052-6","article-title":"Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients","volume":"41","author":"L\u00fctjohann","year":"2000","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0605","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.nbd.2013.03.013","article-title":"PREDICT-HD study group, plasma 24S-hydroxycholesterol correlation with markers of Huntington disease progression","volume":"55","author":"Leoni","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0610","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3233\/JAD-2012-111460","article-title":"Markers of cholesterol metabolism in the brain show stronger associations with cerebrovascular disease than Alzheimer\u2019s disease","volume":"30","author":"Hughes","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0615","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1146\/annurev.med.56.082103.104739","article-title":"Role of magnetic resonance imaging and immunotherapy in treating multiple sclerosis","volume":"56","author":"Zhang","year":"2005","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0620","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1136\/jnnp.2007.128728","article-title":"Detection of Huntington\u2019s disease decades before diagnosis: the Predict-HD study","volume":"79","author":"Paulsen","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.bbalip.2014.12.018_bb0625","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1474-4422(11)70070-9","article-title":"Development of biomarkers for Huntington's disease","volume":"6","author":"Weir","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbalip.2014.12.018_bb0630","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1124\/jpet.105.094136","article-title":"Brain cholesterol synthesis in mice is affected by high dose of simvastatin but not of pravastatin","volume":"316","author":"Thelen","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198115000037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198115000037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T23:45:28Z","timestamp":1690847128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1388198115000037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":123,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S1388198115000037"],"URL":"https:\/\/doi.org\/10.1016\/j.bbalip.2014.12.018","relation":{},"ISSN":["1388-1981"],"issn-type":[{"value":"1388-1981","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impairment of cholesterol metabolism in Huntington disease","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbalip.2014.12.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}